LLA — LungLife AI Balance Sheet
0.000.00%
- £1.07m
- -£0.71m
- $0.05m
Annual balance sheet for LungLife AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 0.128 | 14.6 | 8.01 | 2.83 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0 | 0.049 | 0.15 | 0.175 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.297 | 15.4 | 8.62 | 3.3 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.463 | 0.766 | 0.566 | 0.389 |
| Net Intangible Assets | ||||
| Long Term Notes Receivable | ||||
| Total Assets | 0.774 | 22 | 15 | 9.52 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 11.9 | 1.19 | 1.48 | 1.45 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 12.1 | 1.84 | 1.88 | 1.61 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| ESOP Debt Guarantee | ||||
| Other Equity | ||||
| Total Equity | -11.3 | 20.1 | 13.1 | 7.91 |
| Total Liabilities & Shareholders' Equity | 0.774 | 22 | 15 | 9.52 |
| Total Common Shares Outstanding |